These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35381467)

  • 1. Environmental determinants of Kaposi's sarcoma-associated herpesvirus (KSHV) transmission in rural Uganda (ENDKU study): Contributions to research on KSHV infection and reactivation in African children; A longitudinal cohort study.
    Sabourin KR; Nalwoga A; Whitby D; Newton R; Rochford R
    Cancer Epidemiol; 2022 Jun; 78():102154. PubMed ID: 35381467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda.
    Wakeham K; Webb EL; Sebina I; Nalwoga A; Muhangi L; Miley W; Johnston WT; Ndibazza J; Whitby D; Newton R; Elliott AM
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):228-33. PubMed ID: 23403859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.
    Nalwoga A; Nakibuule M; Marshall V; Miley W; Labo N; Cose S; Whitby D; Newton R
    Clin Infect Dis; 2020 Aug; 71(4):1055-1062. PubMed ID: 31555829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum Malaria Is Associated With Increased Kaposi Sarcoma-Associated Herpesvirus (KSHV) Seropositivity and Higher KSHV Antibody Breadth and Magnitude: Results of a Case-Control Study From Rural Uganda.
    Nalwoga A; Sabourin KR; Miley W; Jackson C; Maktabi M; Labo N; Mugisha J; Whitby D; Rochford R; Newton R
    J Infect Dis; 2024 Feb; 229(2):432-442. PubMed ID: 37536670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria Is Associated With Kaposi Sarcoma-Associated Herpesvirus Seroconversion in a Cohort of Western Kenyan Children.
    Sabourin KR; Daud I; Ogolla S; Labo N; Miley W; Lamb M; Newton R; Whitby D; Rochford R
    J Infect Dis; 2021 Jul; 224(2):303-311. PubMed ID: 33249494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute
    Oluoch PO; Forconi CS; Oduor CI; Ritacco DA; Akala HM; Bailey JA; Juliano JJ; Ong'echa JM; Münz C; Moormann AM
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda.
    Nalwoga A; Cose S; Wakeham K; Miley W; Ndibazza J; Drakeley C; Elliott A; Whitby D; Newton R
    Trop Med Int Health; 2015 May; 20(5):665-672. PubMed ID: 25611008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
    Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
    Ziegler JL; Katongole-Mbidde E
    Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda.
    Wawer MJ; Eng SM; Serwadda D; Sewankambo NK; Kiwanuka N; Li C; Gray RH
    Sex Transm Dis; 2001 Feb; 28(2):77-81. PubMed ID: 11234789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
    J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.
    Mayama S; Cuevas LE; Sheldon J; Omar OH; Smith DH; Okong P; Silvel B; Hart CA; Schulz TF
    Int J Cancer; 1998 Sep; 77(6):817-20. PubMed ID: 9714046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Anemia, Malaria Coinfection, and Kaposi Sarcoma-Associated Herpesvirus Seropositivity in a Population-Based Study in Rural Uganda.
    Nalwoga A; Cose S; Nash S; Miley W; Asiki G; Kusemererwa S; Yarchoan R; Labo N; Whitby D; Newton R
    J Infect Dis; 2018 Aug; 218(7):1061-1065. PubMed ID: 29741631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C
    Br J Cancer; 2003 Aug; 89(3):502-4. PubMed ID: 12888820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
    Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
    Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
    Wakeham K; Johnston WT; Nalwoga A; Webb EL; Mayanja BN; Miley W; Elliott AM; Whitby D; Newton R
    Int J Cancer; 2015 Jun; 136(12):2822-30. PubMed ID: 25395177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism.
    Zong J; Ciufo DM; Viscidi R; Alagiozoglou L; Tyring S; Rady P; Orenstein J; Boto W; Kalumbuja H; Romano N; Melbye M; Kang GH; Boshoff C; Hayward GS
    J Clin Virol; 2002 Jan; 23(3):119-48. PubMed ID: 11595592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.